• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对乳腺钼靶检查发现的不可触及病变进行活检时出现的增殖性疾病和异型性。

Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically.

作者信息

Rubin E, Visscher D W, Alexander R W, Urist M M, Maddox W A

机构信息

Department of Radiology, University of Alabama Medical Center, Birmingham 35233.

出版信息

Cancer. 1988 May 15;61(10):2077-82. doi: 10.1002/1097-0142(19880515)61:10<2077::aid-cncr2820611024>3.0.co;2-m.

DOI:10.1002/1097-0142(19880515)61:10<2077::aid-cncr2820611024>3.0.co;2-m
PMID:3359405
Abstract

A recent study of risk factors for breast cancer indicated elevated risks of 5.3 and 1.9 times, respectively, for women with biopsy specimens showing atypical hyperplasia (AH) and proliferative disease without atypia. These risks increase to 11 and 3.2 times, respectively, in women who also have a family history of breast cancer. This study reviews lesions detected mammographically in a series of patients with documented risk factors. The pathologic specimens of 100 consecutive localization breast biopsies performed for nonpalpable abnormalities detected mammographically were reviewed and classified according to the criteria of Dupont and Page in order to determine the incidence of AH and proliferative breast disease. The mammographic characteristics and historical risk factors of these women also were correlated. Twenty percent of the biopsy specimens showed carcinomas, 55% of which were noninvasive. AH was found in an additional 10% of the biopsy specimens, whereas proliferative disease without atypia occurred in 21% of the biopsy specimens. Forty-nine percent of the biopsy specimens showed nonproliferative changes. This study demonstrated that mammography, in addition to its ability to detect small nonpalpable cancers, identifies a high percentage (31% in this series) of women with pathologic lesions known to have an elevated risk for subsequent breast cancer. The current impetus for large-scale mammographic screening of asymptomatic women mandates the development of rational therapeutic protocols to accommodate the widening spectrum of high-risk pathologic lesions found in these selected populations.

摘要

最近一项关于乳腺癌风险因素的研究表明,活检标本显示非典型增生(AH)的女性患癌风险分别升高5.3倍,患增生性疾病但无异常的女性患癌风险升高1.9倍。对于有乳腺癌家族史的女性,这些风险分别增至11倍和3.2倍。本研究回顾了一系列有记录风险因素的患者经乳房X线检查发现的病变。对因乳房X线检查发现的不可触及异常而连续进行的100例局部乳腺活检的病理标本,按照杜邦和佩奇的标准进行回顾和分类,以确定AH和增生性乳腺疾病的发生率。还将这些女性的乳房X线特征与既往风险因素进行了关联分析。20%的活检标本显示为癌,其中55%为非浸润性癌。另外10%的活检标本发现有AH,而21%的活检标本出现了无异常的增生性疾病。49%的活检标本显示为非增生性改变。本研究表明,乳房X线检查除了能够检测出不可触及的小癌外,还能识别出高比例(本系列中为31%)已知后续患乳腺癌风险升高的有病理病变的女性。当前对无症状女性进行大规模乳房X线筛查的趋势,要求制定合理的治疗方案,以适应在这些特定人群中发现的范围不断扩大的高风险病理病变。

相似文献

1
Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically.对乳腺钼靶检查发现的不可触及病变进行活检时出现的增殖性疾病和异型性。
Cancer. 1988 May 15;61(10):2077-82. doi: 10.1002/1097-0142(19880515)61:10<2077::aid-cncr2820611024>3.0.co;2-m.
2
Ultrasound demonstration of mammographically detected microcalcifications.乳腺钼靶检查发现的微钙化灶的超声表现
Acta Radiol. 2000 May;41(3):217-21. doi: 10.1080/028418500127345370.
3
Mammographically detected breast cancer. Nonpalpable is not a synonym for inconsequential.乳腺钼靶检查发现的乳腺癌。不可触及并不等同于无关紧要。
Cancer. 1994 Mar 15;73(6):1660-5. doi: 10.1002/1097-0142(19940315)73:6<1660::aid-cncr2820730618>3.0.co;2-z.
4
Wire-directed localization biopsy of the breast: an audit of results and analysis of factors influencing therapeutic value in the treatment of breast cancer.乳腺金属丝引导定位活检:乳腺癌治疗中结果审核及影响治疗价值的因素分析
Eur J Surg Oncol. 1997 Apr;23(2):128-33. doi: 10.1016/s0748-7983(97)80005-4.
5
The predictive value of needle localization mammographically assisted biopsy of the breast.乳腺钼靶引导下针定位活检的预测价值。
Surg Gynecol Obstet. 1990 Nov;171(5):361-5.
6
Breast biopsy for nonpalpable lesions: a worthwhile endeavor?不可触及性病变的乳腺活检:一项值得努力的尝试?
Am Surg. 1993 Aug;59(8):490-3; discussion 493-4.
7
Not all nonpalpable breast cancers are alike.并非所有触诊不到的乳腺癌都是一样的。
Arch Surg. 1991 Aug;126(8):967-70; discussion 970-1. doi: 10.1001/archsurg.1991.01410320049005.
8
How thoroughly should needle localization breast biopsies be sampled for microscopic examination? A prospective mammographic/pathologic correlative study.针定位乳腺活检的组织标本应进行多彻底的显微镜检查?一项前瞻性乳腺钼靶/病理相关性研究。
Am J Surg Pathol. 1990 Jun;14(6):578-83. doi: 10.1097/00000478-199006000-00009.
9
Mammographic wire localization in diagnosis and treatment of occult carcinoma of breast.乳腺钼靶钢丝定位在隐匿性乳腺癌诊断与治疗中的应用
Surg Gynecol Obstet. 1989 Mar;168(3):239-43.
10
Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up.非触及性乳腺病变的立体定向、自动、粗针活检:长期随访后的假阴性和组织学低估率
Radiology. 1999 Mar;210(3):799-805. doi: 10.1148/radiology.210.3.r99mr19799.

引用本文的文献

1
Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia.乳腺非典型增生患者的后续乳腺癌诊断轨迹。
Ann Surg Oncol. 2024 Oct;31(11):7550-7558. doi: 10.1245/s10434-024-15788-7. Epub 2024 Jul 21.
2
Opening label, dynamic prospective cohort study on the small focus less than 1.0 cm shown by type B ultrasound in breast.开放性标签、动态前瞻性队列研究,针对乳腺B超显示的小于1.0厘米的小病灶。
Medicine (Baltimore). 2020 May;99(19):e20158. doi: 10.1097/MD.0000000000020158.
3
Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape.
不典型导管增生:诊断、管理和分子特征的最新进展。
Breast Cancer Res. 2018 May 2;20(1):39. doi: 10.1186/s13058-018-0967-1.
4
Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective.病理学家对个体乳腺活检切片解读的变异性:人群视角
Ann Intern Med. 2016 May 17;164(10):649-55. doi: 10.7326/M15-0964. Epub 2016 Mar 22.
5
Diagnostic concordance among pathologists interpreting breast biopsy specimens.解读乳腺活检标本的病理学家之间的诊断一致性。
JAMA. 2015 Mar 17;313(11):1122-32. doi: 10.1001/jama.2015.1405.
6
Current management of lesions associated with an increased risk of breast cancer.与乳腺癌风险增加相关的病变的当前管理。
Nat Rev Clin Oncol. 2015 Apr;12(4):227-38. doi: 10.1038/nrclinonc.2015.8. Epub 2015 Jan 27.
7
Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches.导管原位癌和乳腺癌发生的分子流行病学研究机遇:跨学科方法
Breast Dis. 2014;34(3):105-16. doi: 10.3233/BD-130359.
8
Biologic characteristics of premalignant breast disease.癌前乳腺疾病的生物学特性。
Cancer Biomark. 2010;9(1-6):177-92. doi: 10.3233/CBM-2011-0187.
9
Epithelial atypia in biopsies performed for microcalcifications. practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up.因微钙化进行活检时的上皮异型性。对2833例连续切片的手术活检进行长期随访的实际考量。
Virchows Arch. 2007 Jul;451(1):1-10. doi: 10.1007/s00428-007-0408-5. Epub 2007 Jun 6.
10
Anatomic indicators (histologic and cytologic) of increased breast cancer risk.乳腺癌风险增加的解剖学指标(组织学和细胞学)
Breast Cancer Res Treat. 1993 Nov;28(2):157-66. doi: 10.1007/BF00666428.